RVNC

Nottingham Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Nottingham Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,979	Closed	-$30.8K	–	172
2024 Q2	$30.8K	Hold	11,979	–	–	﹤0.01%	155
2024 Q1	$58.9K	Hold	11,979	–	–	0.01%	136
2023 Q4	$105K	Hold	11,979	–	–	0.01%	129
2023 Q3	$137K	Hold	11,979	–	–	0.02%	123
2023 Q2	$303K	Sell	11,979 -200	-2%	-$5.06K	0.04%	106
2023 Q1	$392K	Sell	12,179 -1,133	-9%	-$36.5K	0.05%	102
2022 Q4	$246K	Hold	13,312	–	–	0.03%	128
2022 Q3	$359K	Hold	13,312	–	–	0.05%	99
2022 Q2	$184K	Hold	13,312	–	–	0.03%	124
2022 Q1	$260K	Hold	13,312	–	–	0.03%	121
2021 Q4	$217K	Hold	13,312	–	–	0.02%	139
2021 Q3	$371K	Hold	13,312	–	–	0.04%	104
2021 Q2	$395K	Hold	13,312	–	–	0.04%	102
2021 Q1	$372K	Hold	13,312	–	–	0.04%	110
2020 Q4	$377K	Hold	13,312	–	–	0.05%	100
2020 Q3	$335K	Hold	13,312	–	–	0.04%	104
2020 Q2	$349	Buy	13,312 +2,000	+18%	+$52	0.02%	95
2020 Q1	$167K	Buy	11,312 +1,308	+13%	+$19.3K	0.03%	106
2019 Q4	$162K	Sell	10,004 -2,000	-17%	-$32.4K	0.02%	107
2019 Q3	$156K	Buy	12,004 +2,000	+20%	+$26K	0.02%	106
2019 Q2	$130K	Hold	10,004	–	–	0.02%	109
2019 Q1	$158K	Sell	10,004 -1,308	-12%	-$20.7K	0.02%	104
2018 Q4	$281K	Hold	11,312	–	–	0.04%	88
2018 Q3	$281K	Hold	11,312	–	–	0.04%	85
2018 Q2	$348K	Hold	11,312	–	–	0.05%	71
2018 Q1	$348K	Hold	11,312	–	–	0.06%	63
2017 Q4	$404K	Hold	11,312	–	–	0.06%	78
2017 Q3	$312K	Sell	11,312 -2,000	-15%	-$55.2K	0.04%	86
2017 Q2	$351K	Hold	13,312	–	–	0.05%	83
2017 Q1	$277K	Hold	13,312	–	–	0.04%	90
2016 Q4	$276K	Hold	13,312	–	–	0.05%	93
2016 Q3	$216K	Sell	13,312 -3,000	-18%	-$48.7K	0.04%	105
2016 Q2	$222K	Sell	16,312 -2,016	-11%	-$27.4K	0.04%	80
2016 Q1	$626K	Hold	18,328	–	–	0.12%	57
2015 Q4	$626K	Hold	18,328	–	–	0.12%	57
2015 Q3	$545K	Hold	18,328	–	–	0.1%	62
2015 Q2	$586K	Sell	18,328 -436	-2%	-$13.9K	0.1%	67
2015 Q1	$389K	Sell	18,764 -4,254	-18%	-$88.2K	0.06%	72
2014 Q4	$390K	Buy	+23,018	New	+$390K	0.1%	65